The Pharmaceutical Journal
Vol 269 No 7222 p637
2 November 2002

This article
Reprint
Photocopy

News summary

Related websites
Cancer Research UK (www.cancerresearchuk.org)

Cancer cells selectively targeted

A new drug that selectively targets breast cancer cells is expected to enter clinical trials early next year.

The drug, "phortress", may be effective in up to a quarter of breast cancers and does not rely on the presence of the oestrogen receptor. It may be possible to test tumours for their susceptibility to the drug, Nottingham University report at the Cancer Research UK annual conference in Warwickshire, this week.